Key Details
Price
$6.47Annual Revenue
$448.27 MAnnual EPS
-$1.06Annual ROE
-0.81%Beta
0.00Events Calendar
Next earnings date:
Aug 15, 2025Recent quarterly earnings:
Aug 16, 2024Recent annual earnings:
Apr 30, 2020Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
20 Mar '14 Morgan Stanley
Overweight13 Nov '13 Aegis Capital
Buy15 Aug '13 Aegis Capital
Buy15 May '13 Morgan Stanley
Equal-Weight14 Mar '13 Aegis Capital
Hold12 Dec '12 Aegis Capital
HoldMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Sinovac Biotech doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
FAQ
- What is the primary business of Sinovac Biotech?
- What is the ticker symbol for Sinovac Biotech?
- Does Sinovac Biotech pay dividends?
- What sector is Sinovac Biotech in?
- What industry is Sinovac Biotech in?
- What country is Sinovac Biotech based in?
- When did Sinovac Biotech go public?
- Is Sinovac Biotech in the S&P 500?
- Is Sinovac Biotech in the NASDAQ 100?
- Is Sinovac Biotech in the Dow Jones?
- When was Sinovac Biotech's last earnings report?
- When does Sinovac Biotech report earnings?
- Should I buy Sinovac Biotech stock now?
What is the primary business of Sinovac Biotech?
Sinovac Biotech is a Chinese biopharmaceutical company that focuses on developing and producing vaccines. It is known for its work on vaccines for diseases like hepatitis A, influenza, and COVID-19. The company aims to improve public health through innovative vaccine solutions.
What is the ticker symbol for Sinovac Biotech?
The ticker symbol for Sinovac Biotech is NASDAQ:SVA
Does Sinovac Biotech pay dividends?
No, Sinovac Biotech does not pay dividends
What sector is Sinovac Biotech in?
Sinovac Biotech is in the Healthcare sector
What industry is Sinovac Biotech in?
Sinovac Biotech is in the Biotechnology industry
What country is Sinovac Biotech based in?
Sinovac Biotech is headquartered in China
When did Sinovac Biotech go public?
Sinovac Biotech's initial public offering (IPO) was on 26 September 2003
Is Sinovac Biotech in the S&P 500?
No, Sinovac Biotech is not included in the S&P 500 index
Is Sinovac Biotech in the NASDAQ 100?
No, Sinovac Biotech is not included in the NASDAQ 100 index
Is Sinovac Biotech in the Dow Jones?
No, Sinovac Biotech is not included in the Dow Jones index
When was Sinovac Biotech's last earnings report?
Sinovac Biotech's most recent earnings report was on 16 August 2024
When does Sinovac Biotech report earnings?
The next expected earnings date for Sinovac Biotech is 15 August 2025
Should I buy Sinovac Biotech stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions